Merck’s drug for bacterial infection leads to fatal diarrhea
merck
December, 24 2024
(Web Desk) Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.

The antibody drug, Zinplava, was first approved by the regulator in 2016 to prevent the recurrence of Clostridioides difficile infections (CDI).

CDI is generally caused by prolonged use of antibiotics, and can lead to potentially fatal diarrhea and inflammation of the colon.

The drugmaker did not immediately comment on the matter.

Zinplava will be discontinued on Jan. 31, the regulator s website showed, but no reason was cited for the decision.

          
Must Read
Image
Smartphone revolution: Apple’s first foldable iPhone may change everything
December, 11 2025
Image
NADRA’s new procedure allows CNIC issuance without parents or siblings
December, 11 2025
Image
Australia opens fully funded scholarships for Pakistani students
December, 11 2025
Image
Daraz 12.12 Sale: TCL offers mega vouchers and discounts
December, 10 2025